Mar 1, 2019 4:05 pm EST EyeGate Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Business Update
Jan 29, 2019 6:55 am EST EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City
Nov 13, 2018 4:05 pm EST EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
Oct 2, 2018 6:55 am EDT EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
Sep 25, 2018 6:55 am EDT EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules
Sep 24, 2018 6:55 am EDT EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies